6-K
Table of Contents

Securities and Exchange Commission

Washington, D.C. 20549

 

 

Form 6-K

 

 

Report of Foreign Issuer

Pursuant to Rule 13a-16 of 15d/16

of the Securities Exchange Act of 1934

May 2016

 

 AEGON N.V.

 

 

Aegonplein 50

2591 TV  THE HAGUE

The Netherlands


Table of Contents

Aegon’s condensed consolidated interim financial statements Q1 2016, dated May 12, 2016, are included as appendix and incorporated herein by reference.

SIGNATURE

Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned, thereunto duly authorized.

 

  

AEGON N.V.

  

 

(Registrant)

Date: May 12, 2016    By     /s/ J.H.P.M. van Rossum
      Executive Vice President and
      Corporate Controller


Table of Contents

LOGO


Table of Contents
 

 

  Condensed Consolidated Interim Financial Statements Q1 2016  

 

 

 

     1      

 

 

Table of contents

 

Condensed consolidated income statement

     2   

Condensed consolidated statement of comprehensive income

     3   

Condensed consolidated statement of financial position

     4   

Condensed consolidated statement of changes in equity

     5   

Condensed consolidated cash flow statement

     6   

Notes to the condensed consolidated interim financial statements

     7   

 

 

 

 

 

 

Unaudited

   LOGO


Table of Contents

 

     2       

 

 

 

  Condensed Consolidated Interim Financial Statements Q1 2016  

 

 

 

Condensed consolidated income statement                     
                       

EUR millions

    Notes        Q1 2016        Q1 2015   
   

Premium income

    4        5,836        6,347   

Investment income

    5        1,935        2,098   

Fee and commission income

      602        582   

Other revenues

            1        2   

Total revenues

      8,374        9,028   

Income from reinsurance ceded

      720        686   

Results from financial transactions

    6        2,050        9,905   

Total income

      11,146        19,618   
   

Benefits and expenses

    7        10,901        19,127   

Impairment charges / (reversals)

    8        40        13   

Interest charges and related fees

      97        108   

Other charges

            -        11   

Total charges

      11,039        19,258   
   

Share in net result of joint ventures

      31        29   

Income / (loss) before tax

      138        389   

Income tax (expense) / benefit

            6        (100

Net income / (loss)

            143        289   
   

Net income / (loss) attributable to:

       

Equity holders of Aegon N.V.

      143        289   

Non-controlling interests

            -        -   
   

Earnings per share (EUR per share)

    15         

Basic earnings per common share

      0.05        0.12   

Basic earnings per common share B

      -        -   

Diluted earnings per common share

      0.05        0.12   

Diluted earnings per common share B

            -        -   

Amounts for 2015 have been restated for the voluntary changes in accounting policies for deferred cost of reinsurance and insurance accounting in the UK. Refer to note 2.1 Voluntary changes in accounting policies for details about these changes.

 

 

LOGO

  

Unaudited


Table of Contents
 

 

  Condensed Consolidated Interim Financial Statements Q1 2016  

 

 

 

     3      

 

 

Condensed consolidated statement of comprehensive income

 

 
EUR millions   Q1 2016     Q1 2015  
   

Net income / (loss)

    143        289   
   

Other comprehensive income:

     

Items that will not be reclassified to profit or loss:

     

Changes in revaluation reserve real estate held for own use

    (2     5   

Remeasurements of defined benefit plans

    (501     (627

Income tax relating to items that will not be reclassified

    135        159   
   

Items that may be reclassified subsequently to profit or loss:

     

Gains / (losses) on revaluation of available-for-sale investments

    1,841        1,595   

(Gains) / losses transferred to the income statement on disposal and impairment of available-for-sale investments

    (30     (132

Changes in cash flow hedging reserve

    304        558   

Movement in foreign currency translation and net foreign investment hedging reserve

    (734     1,718   

Equity movements of joint ventures

    3        3   

Equity movements of associates

    1        -   

Income tax relating to items that may be reclassified

    (762     (450

Other

    6        3   

Other comprehensive income for the period

    261        2,831   

Total comprehensive income / (loss)

    405        3,120   
   

Total comprehensive income / (loss) attributable to:

     

Equity holders of Aegon N.V.

    398        3,119   

Non-controlling interests

    7        -   

Amounts for 2015 have been restated for the voluntary changes in accounting policies for deferred cost of reinsurance and insurance accounting in the UK. Refer to note 2.1 Voluntary changes in accounting policies for details about these changes.

 

 

Unaudited

   LOGO


Table of Contents

 

     4       

 

 

 

  Condensed Consolidated Interim Financial Statements Q1 2016  

 

 

 

Condensed consolidated statement of financial position

 

 
            Mar. 31,
2016
    Dec. 31,
2015
 

EUR millions

    Notes                   
   

Assets

       

Intangible assets

    9        1,815        1,901   

Investments

    10        162,784        160,792   

Investments for account of policyholders

    11        191,286        200,226   

Derivatives

    12        17,288        11,545   

Investments in joint ventures

      1,558        1,561   

Investments in associates

      252        242   

Reinsurance assets

      10,588        11,257   

Deferred expenses

    14        10,299        10,997   

Other assets and receivables

      8,117        7,615   

Cash and cash equivalents

            10,616        9,594   

Total assets

      414,602        415,729   
   

Equity and liabilities

       

Shareholders’ equity

      22,848        22,684   

Other equity instruments

            3,811        3,800   

Issued capital and reserves attributable to equity holders of Aegon N.V.

      26,659        26,485   

Non-controlling interests

            16        9   

Group equity

      26,674        26,494   
   

Trust pass-through securities

      153        157   

Subordinated borrowings

      757        759   

Insurance contracts

      122,099        123,042   

Insurance contracts for account of policyholders

      108,736        112,679   

Investment contracts

      18,010        17,718   

Investment contracts for account of policyholders

      85,321        90,119   

Derivatives

    12        16,468        10,890   

Borrowings

    16        10,806        12,445   

Other liabilities

            25,577        21,427   

Total liabilities

 

            387,928        389,236   

Total equity and liabilities

            414,602        415,729   

Amounts for 2015 have been restated for the voluntary changes in accounting policies for deferred cost of reinsurance and insurance accounting in the UK. Refer to note 2.1 Voluntary changes in accounting policies for details about these changes.

 

 

LOGO

   Unaudited


Table of Contents
 

 

  Condensed Consolidated Interim Financial Statements Q1 2016  

 

 

 

     5      

 

 

Condensed consolidated statement of changes in equity

 

 
EUR millions   Share
capital 1
    Retained
earnings
    Revaluation
reserves
    Remeasurement
of defined
benefit plans
    Other
reserves
    Other equity
instruments
    Issued
capital and
reserves  2
    Non-
controlling
interests
    Total  
       

Three months ended March 31, 2016

                       
       

At beginning of year

    8,387        8,075        6,471        (1,532     1,283        3,800        26,485        9        26,494   
       

Net income / (loss) recognized in the income statement

    -        143        -        -        -        -        143        -        143   
       

Other comprehensive income:

                       

Items that will not be reclassified to profit or loss:

                       

Changes in revaluation reserve real estate held for own use

    -        -        (2     -        -        -        (2     -        (2

Remeasurements of defined benefit plans

    -        -        -        (501     -        -        (501     -        (501

Income tax relating to items that will not be reclassified

    -        -        -        136        -        -        135        -        135   
       

Items that may be reclassified subsequently to profit or loss:

                       

Gains / (losses) on revaluation of available-for-sale investments

    -        -        1,841        -        -        -        1,841        -        1,841   

(Gains) / losses transferred to income statement on disposal and impairment of available-for-sale investments

    -        -        (30     -        -        -        (30     -        (30

Changes in cash flow hedging reserve

    -        -        304        -        -        -        304        -        304   

Movement in foreign currency translation and net foreign investment hedging reserves

    -        -        -        53        (787     -        (734     -        (734

Equity movements of joint ventures

    -        -        -        -        3        -        3        -        3   

Equity movements of associates

    -        -        -        -        1        -        1        -        1   

Income tax relating to items that may be reclassified

    -        -        (776     -        14        -        (762     -        (762

Other

    -        (1     -        -        -        -        (1     7        6   

Total other comprehensive income

    -        (1     1,337        (313     (769     -        255        7        261   

Total comprehensive income / (loss) for 2016

    -        143        1,337        (313     (769     -        398        7        405   
       

Issuance and purchase of (treasury) shares

    -        (200     -        -        -        -        (200     -        (200

Coupons on non-cumulative subordinated notes

    -        (7     -        -        -        -        (7     -        (7

Coupons on perpetual securities

    -        (28     -        -        -        -        (28     -        (28

Incentive plans

    -        -        -        -        -        11        11        -        11   

At end of period

    8,387        7,984        7,808        (1,845     513        3,811        26,659        16        26,674   
       

Three months ended March 31, 2015

                       
       

At beginning of year (as previously stated)

    8,597        9,076        8,308        (1,611     (77     3,827        28,120        9        28,129   
       

Changes in accounting policies relating to deferred cost of reinsurance

    -        (101     -        -        (9     -        (110     -        (110
       

At beginning of year (restated)

    8,597        8,975        8,308        (1,611     (86     3,827        28,010        9        28,019   
       

Net income / (loss) recognized in the income statement

    -        289        -        -        -        -        289        -        289   
       

Other comprehensive income:

                       

Items that will not be reclassified to profit or loss:

                       

Changes in revaluation reserve real estate held for own use

    -        -        5        -        -        -        5        -        5   

Remeasurements of defined benefit plans

    -        -        -        (627     -        -        (627     -        (627

Income tax relating to items that will not be reclassified

    -        -        -        159        -        -        159        -        159   
       

Items that may be reclassified subsequently to profit or loss:

                       

Gains / (losses) on revaluation of available-for-sale investments

    -        -        1,595        -        -        -        1,595        -        1,595   

(Gains) / losses transferred to income statement on disposal and impairment of available-for-sale investments

    -        -        (132     -        -        -        (132     -        (132

Changes in cash flow hedging reserve

    -        -        558        -        -        -        558        -        558   

Movement in foreign currency translation and net foreign investment hedging reserves

    -        -        -        (104     1,823        -        1,718        -        1,718   

Equity movements of joint ventures

    -        -        -        -        3        -        3        -        3   

Income tax relating to items that may be reclassified

    -        -        (400     -        (50     -        (450     -        (450

Other

    -        3        -        -        -        -        3        -        3   

Total other comprehensive income

    -        3        1,625        (573     1,776        -        2,830        -        2,831   

Total comprehensive income / (loss) for 2015

    -        292        1,625        (573     1,776        -        3,119        -        3,120   
       

Issuance and purchase of (treasury) shares

    -        1        -        -        -        -        1        -        1   

Coupons on non-cumulative subordinated notes

    -        (7     -        -        -        -        (7     -        (7

Coupons on perpetual securities

    -        (30     -        -        -        -        (30     -        (30

Share options and incentive plans

    -        10        -        -        -        (2     8        -        8   

At end of period

    8,597        9,242        9,933        (2,184     1,690        3,825        31,102        9        31,111   

 

1

For a breakdown of share capital please refer to note 15.

2

Issued capital and reserves attributable to equity holders of Aegon N.V.

Amounts for 2015 have been restated for the voluntary changes in accounting policies for deferred cost of reinsurance and insurance accounting in the UK. Refer to note 2.1 Voluntary changes in accounting policies for details about these changes.

 

 

Unaudited

   LOGO


Table of Contents

 

     6       

 

 

 

  Condensed Consolidated Interim Financial Statements Q1 2016  

 

 

 

Condensed consolidated cash flow statement

 

 
EUR millions   Q1 2016     Q1 2015  
   

Cash flow from operating activities

    2,799        2,338   
   

Purchases and disposals of intangible assets

    (8     (2

Purchases and disposals of equipment and other assets

    (8     (15

Purchases, disposals and dividends of subsidiaries, associates and joint ventures

    23        330   

Cash flow from investing activities

    6        313   
   

Issuance and purchase of (treasury) shares

    (200     -   

Issuances, repurchases and coupons of perpetuals

    (37     (39

Issuances, repurchases and coupons of non-cumulative subordinated notes

    (9     (9

Issuances and repayments of borrowings

    (1,431     (210

Cash flow from financing activities

    (1,677     (258
   

Net increase / (decrease) in cash and cash equivalents

    1,128        2,393   

Net cash and cash equivalents at January 1

    9,593        10,649   

Effects of changes in foreign exchange rates

    (146     235   

Net cash and cash equivalents at end of period

    10,576        13,277   
   
                 

Cash and cash equivalents

    10,616        13,236   

Cash and cash equivalents classified as Assets held for sale

    -        46   

Bank overdrafts classified as other liabilities

    (40     (4

Net cash and cash equivalents

    10,576        13,277   

 

 

LOGO

   Unaudited


Table of Contents
 

 

  Condensed Consolidated Interim Financial Statements Q1 2016  

 

 

 

     7      

 

 

Notes to the condensed consolidated interim financial statements

Amounts in EUR millions, unless otherwise stated

Aegon N.V., incorporated and domiciled in the Netherlands, is a public limited liability company organized under Dutch law and recorded in the Commercial Register of The Hague under number 27076669 and with its registered address at Aegonplein 50, 2591 TV, The Hague, the Netherlands. Aegon N.V. serves as the holding company for the Aegon Group and has listings of its common shares in Amsterdam and New York.

Aegon N.V. (or ‘the Company’) and its consolidated subsidiaries (‘Aegon’ or ‘the Group’) have life insurance and pensions operations in over twenty five countries in the Americas, Europe and Asia and are also active in savings and asset management operations, accident and health insurance, general insurance and to a limited extent banking operations. Its headquarters are located in The Hague, the Netherlands. The Group employs close to 30,000 people worldwide.

1. Basis of presentation

The condensed consolidated interim financial statements as at, and for the period ended, March 31, 2016, have been prepared in accordance with IAS 34 ‘Interim Financial Reporting’, as adopted by the European Union (hereafter ‘IFRS’). They do not include all of the information required for a full set of financial statements prepared in accordance with IFRS and should therefore be read together with the 2015 consolidated financial statements of Aegon N.V. as included in Aegon’s Annual Report for 2015 and the disclosures provided in note 2.1 of this report which disclose the impact of voluntary changes in accounting policies that were made by Aegon effective January 1, 2016. Aegon’s Annual Report for 2015 is available on its website (aegon.com).

The condensed consolidated interim financial statements have been prepared in accordance with the historical cost convention as modified by the revaluation of investment properties and those financial instruments (including derivatives) and financial liabilities that have been measured at fair value.

The condensed consolidated interim financial statements as at, and for the period ended, March 31, 2016, were approved by the Executive Board on May 11, 2016.

The condensed consolidated interim financial statements are presented in euro (EUR) and all values are rounded to the nearest million unless otherwise stated. The consequence is that the rounded amounts may not add up to the rounded total in all cases.

The published figures in these condensed consolidated interim financial statements are unaudited.

2. Significant accounting policies

All accounting policies and methods of computation applied in the condensed consolidated interim financial statements are the same as those applied in the 2015 consolidated financial statements, except for the newly applied accounting policies as described in note 2.1.

 

 

Unaudited

   LOGO


Table of Contents

 

     8       

 

 

 

  Condensed Consolidated Interim Financial Statements Q1 2016  

 

 

 

New IFRS accounting standards effective

The following standards, interpretations, amendments to standards and interpretations became effective in 2016:

 

t  

IFRS 10, IFRS 12 and IAS 28 - Investment Entities: Applying the Consolidation Exception;

t  

IFRS 11 Joint Arrangements - Amendment Accounting for Acquisition of Interests in Joint Operations;

t  

IFRS 14 Regulatory Deferral Accounts;

t  

IAS 1 - Amendment Disclosure Initiative;

t  

IAS 27 Separate Financial Statements - Amendment Equity method in Separate Financial Statements;

t  

IAS 16 and IAS 38 Clarification of Acceptable Methods of Depreciation and Amortization; and

t  

Annual improvements 2012-2014 Cycle.

None of these revised standards and interpretations had a significant effect on the condensed consolidated interim financial statements as at and for the period ended March 31, 2016.

For a complete overview of IFRS standards, published before January 1, 2016, that will be applied in future years, and were not early adopted by the Group, please refer to Aegon’s Annual Report for 2015.

Taxes

Taxes on income for the three month period, ended March 31, 2016, are calculated using the tax rate that would be applicable to total annual earnings.

Judgments and critical accounting estimates

Preparing the condensed consolidated interim financial statements requires management to make judgments, estimates and assumptions, including the likelihood, timing or amount of future transactions or events, that affect the application of accounting policies and the reported amounts of assets and liabilities, income and expense. Actual results may differ from the estimates made.

In preparing the condensed consolidated interim financial statements, significant judgments made by management in applying the Group’s accounting policies and the key sources of estimating uncertainty were not significantly different than those that were applied to the consolidated financial statements as at and for the year ended December 31, 2015.

Exchange rates

Assets and liabilities are translated at the closing rates on the balance sheet date. Income, expenses and capital transactions (such as dividends) are translated at average exchange rates or at the prevailing rates on the transaction date, if more appropriate. The following exchange rates are applied for the condensed consolidated interim financial statements:

Closing exchange rates

                         USD         GBP   

March 31, 2016

     1         EUR         1.1396         0.7928   

December 31, 2015

     1         EUR         1.0863         0.7370   

Weighted average exchange rates

                         USD         GBP   

Three months ended March 31, 2016

     1         EUR         1.1023         0.7698   

Three months ended March 31, 2015

     1         EUR         1.1272         0.7434   

 

 

LOGO

  

Unaudited


Table of Contents
 

 

  Condensed Consolidated Interim Financial Statements Q1 2016  

 

 

 

     9      

 

 

2.1 Voluntary changes in accounting policies

On January 13, 2016, Aegon provided an update on its strategic plans at its Analyst & Investor Conference. Following this update Aegon adopted voluntary changes in accounting policies, effective January 1, 2016, which are applied retrospectively for all periods presented. Firstly, Aegon adopted a group-wide accounting policy for reinsurance transactions that are entered into as part of a plan to exit a business. Also, Aegon made two voluntary accounting policy changes that better reflect its business strategy after restructuring in the United Kingdom. The changes in the United Kingdom do not impact other reporting units within Aegon as these are changes specific to Aegon UK. However, these changes do increase alignment with other reporting units within Aegon. Finally Aegon changed its segment reporting.

In the paragraphs below, details are provided for the changes in accounting policies including the impact on shareholders equity and net income. The changes in segment reporting are explained in note 3.

Accounting related to certain reinsurance transactions

Aegon adopted one single group-wide accounting policy for reinsurance transactions that are entered into as part of a plan to exit a business. The previous accounting policy recorded a deferred cost of reinsurance which was subsequently amortized. Under the new accounting policy, when the company enters into a reinsurance contract as part of a plan to exit a business, an immediate gain or loss will be recognized in the income statement.

For purposes of this accounting policy, a business is defined as “designated insurance liabilities to be disposed of through reinsurance transactions”. The insurance liabilities are designated according to their homogenous risk profiles, possible examples include but are not limited to geographical area, product type, distribution channel, policyholder profiles, and policy form or riders.

Insurance accounting for business in United Kingdom

In January 2016, Aegon announced the restructuring of its business and operations in the UK. This involves splitting the Aegon UK business into three components: the annuity business, the traditional pension book and the new digital solutions platform. By extracting the digital solutions platform from the rest of the business, management aims to ensure the focus and separate culture required to successfully build a viable and sustainably growing business over the longer term.

Aegon adopts two voluntary accounting policy changes that better reflect its business strategy after restructuring in the United Kingdom, only affecting Aegon UK. The changes involve the aggregation level at which the liability adequacy test is carried out and the definition of when a substantially modified contract will be derecognized.

Level of aggregation

The previous accounting policy for the level of aggregation for the liability adequacy test in the United Kingdom was on a geographical basis, therefore the total Aegon UK book is considered as one population. After the announced restructuring, Aegon’s business in the United Kingdom has been split into different portfolios that are managed independently from one another. Management is of the opinion that the liability adequacy test should be disaggregated to a portfolio level to reflect this change in strategy. This change in the definition of portfolio for Aegon UK will better align with other reporting units in the Group where insurance contracts are grouped consistent with the Company’s manner of acquiring, servicing and measuring the profitability of its insurance contracts.

 

 

Unaudited

   LOGO


Table of Contents

 

     10       

 

 

 

  Condensed Consolidated Interim Financial Statements Q1 2016  

 

 

 

Substantial modification

The previous accounting policy for Aegon’s business in the United Kingdom is to derecognize insurance contracts when legal extinguishment occurs. As the annuity business, the traditional pension book and the new digital solutions platform will be managed separately post-restructuring, Aegon has decided to change its accounting policy for Aegon UK to one that applies criteria from IAS 39 contract modification. Under these criteria a change should be significant enough to be considered an extinguishment of the existing contract and the issuance of a new contract. Aegon considers that this change in accounting policy is preferred as introducing a more sophisticated approach to contract modification is consistent with how the business will be managed post-restructuring. Furthermore, it will provide the user with information that is more relevant and that reliably reflects the economic substance of our transactions with our upgraded policyholders, as required by IFRS 4 and IAS 8, in relation to the nature of contract modifications.

Details of the impact of the adjustments on previous periods are provided in the following tables:

 

Impact of voluntary changes in accounting policies on condensed consolidated income statement  
    
                      Change in accounting policy           
      Notes        Q1 2015  1)     
 
Deferred cost of
reinsurance
  
  
   
 
 
Insurance
accounting in
UK
  
  
  
    Q1 2015 (restated)   

EUR millions

                                       
   

Premium income

    4        5,641        -        706        6,347   

Benefits and expenses

    7        18,392        (8     743        19,127   
   

Income tax (expense) / benefit

      (101     (6     7        (100
   

Impact on net income

                    2        (29        
   

Earnings per share (EUR per share)

    15             

Basic earnings per common share

      0.13        -        (0.01     0.12   

Basic earnings per common share B

      -        -        -        -   

Diluted earnings per common share

      0.13        -        (0.01     0.12   

Diluted earnings per common share B

            -        -        -        -   
   

Earnings per share calculation

    15             

Net income / (loss) attributable to equity holders of Aegon N.V.

      316        2        (29     289   

Coupons on other equity instruments

            (36     -        -        (36

Earnings attributable to common shares and common shares B

      280        2        (29     253   
   

Weighted average number of common shares outstanding (in million)

      2,095        -        -        2,095   

Weighted average number of common shares B outstanding (in million)

            581        -        -        581   

 

1

Note that premium income and expenses have been updated for the adjustments made in Q2 2015.

 

 

LOGO

   Unaudited


Table of Contents
 

 

  Condensed Consolidated Interim Financial Statements Q1 2016  

 

 

 

     11      

 

 

 

Impact of voluntary changes in accounting policies on condensed consolidated income statement

 

 
          Change in accounting policy       
      Notes       
 
 
FY 2015 (as
previously
reported)  1)
  
  
  
   
 
Deferred cost of
reinsurance
  
  
   

 
 

Insurance

accounting in
UK

  

  
  

    FY 2015 (restated)   

EUR millions

                                       
   

Premium income

    4        20,311        -        2,614        22,925   

Benefits and expenses

    7        33,325        (36     2,763        36,052   

Impairment charges / (reversals)

    8        (22     -        1,274        1,251   
   

Income tax (expense) / benefit

      (134     (26     270        111   
   

Impact on net income

                    10        (1,153        
   

Earnings per share (EUR per share)

    15             

Basic earnings per common share

      0.23        -        (0.54     (0.31

Basic earnings per common share B

      0.01        -        (0.01     (0.01

Diluted earnings per common share

      0.23        -        (0.54     (0.31

Diluted earnings per common share B

            0.01        -        (0.01     (0.01
   

Earnings per share calculation

    15             

Net income / (loss) attributable to equity holders of Aegon N.V.

      619        10        (1,153     (524

Coupons on other equity instruments

            (139     -        -        (139

Earnings attributable to common shares and common shares B

      479        10        (1,153     (663
   

Weighted average number of common shares outstanding (in million)

      2,101        -        -        2,101   

Weighted average number of common shares B outstanding (in million)

            584        -        -        584   

 

1

As reported in Aegon’s 2015 Annual Report dated March 25, 2016.

 

Impact of voluntary changes in accounting policies on condensed consolidated statement of comprehensive
income
 
                Change in accounting policy           
      
 
 
Q1 2015 (as
previously
reported)
  
  
  
    
 
Deferred cost of
reinsurance
  
  
   
 
 
Insurance
accounting in
UK
  
  
  
    Q1 2015 (restated)   

EUR millions

                                 
   

Net income

     316         2        (29     289   
   

Items that may be reclassified subsequently to profit or loss:

           

Movement in foreign currency translation and net foreign investment hedging reserves

     1,733         (14     (1     1,718   

Impact on comprehensive income

              (11     (30        
   

Total comprehensive income / (loss) attributable to:

           

Equity holders of Aegon N.V.

     3,161         (11     (30     3,119   

Non-controlling interests

     -         -        -        -   

 

Impact of voluntary changes in accounting policies on condensed consolidated statement of comprehensive
income
 
              Change in accounting policy           
     
 
 
FY 2015 (as
previously
reported)  1)
  
  
  
   
 
Deferred cost of
reinsurance
  
  
   
 
 
Insurance
accounting in
UK
  
  
  
    FY 2015 (restated)   

EUR millions

                               
   

Net income

    619        10        (1,153     (523
   

Items that may be reclassified subsequently to profit or loss:

         

Movement in foreign currency translation and net foreign investment hedging reserves

    1,414        (12     18        1,419   

Impact on comprehensive income

            (2     (1,135        
   

Total comprehensive income / (loss) attributable to:

         

Equity holders of Aegon N.V.

    234        (2     (1,135     (903

Non-controlling interests

    -        -        -        -   

 

1

As reported in Aegon’s 2015 Annual Report dated March 25, 2016.

 

 

Unaudited

  

 

LOGO


Table of Contents

 

     12       

 

 

 

  Condensed Consolidated Interim Financial Statements Q1 2016  

 

 

 

Impact of changes in accounting policies on the condensed consolidated statement of financial position  
    
          Change in accounting policy       
      Notes       

 

 

 

December 31,

2015 (as

previously

reported) 1)

  

  

  

  

   
 
Deferred cost of
reinsurance
  
  
   
 

 

Insurance
accounting in

UK

  
  

  

   
 
 
December 31,
2015
(restated)
  
  
  

EUR millions

                                       
   

Assets

           

Intangible assets

    9        2,110        -        (210     1,901   

Deferred expenses

    14        12,547        (358     (1,192     10,997   
   

Equity and liabilities

           

Shareholders’ equity

      23,931        (112     (1,135     22,684   
   

Insurance contracts

      123,042        -        -        123,042   

Investment contracts

      17,718        -        -        17,718   

Other liabilities

            21,940        (247     (266     21,427   

 

1

As reported in Aegon’s 2015 Annual Report dated March 25, 2016.

 

Impact of voluntary changes in accounting policies on condensed consolidated statement of changes in equity  
    
        Change in accounting policy       
     

 

 

 

December 31,

2015 (as

previously

reported) 1)

  

  

  

  

   
 
Deferred cost of
reinsurance
  
  
   
 

 

Insurance
accounting in

UK

  
  

  

   
 
 
December 31,
2015
(restated)
  
  
  

EUR millions

                               
   

Share capital

    8,387        -        -        8,387   

Retained earnings

    9,319        (91     (1,153     8,075   

Revaluation reserves

    6,471        -        -        6,471   

Remeasurement of defined benefit plans

    (1,532     -        -        (1,532

Other reserves

    1,286        (21     18        1,283   

Shareholders’ equity

    23,931        (112     (1,135     22,684   

 

1

As reported in Aegon’s 2015 Annual Report dated March 25, 2016.

 

 

LOGO

  

Unaudited


Table of Contents
 

 

  Condensed Consolidated Interim Financial Statements Q1 2016  

 

 

 

     13      

 

 

3. Segment information

Based on the amended strategic plans as announced on January 13, 2016, Aegon has reconsidered its segment reporting. Aegon’s current segment reporting was established in 2010 considering the requirements outlined in IFRS 8 – Operating Segments. IFRS 8 requires operating segments to be defined in line with how the ‘chief operating decision maker’ (CODM, i.e. Aegon’s Executive Board) manages the business. Currently, Aegon has the following reportable segments: Americas, The Netherlands, United Kingdom, New Markets and Holdings and other activities. New Markets was established to aggregate Aegon’s emerging businesses and global / European initiatives which is a combination of the following operating segments: Central & Eastern Europe, Asia, Spain & Portugal, Asset Management and Variable Annuities Europe (VA Europe). Under IFRS 8 these operating segments were aggregated as one reportable segment due to their respective size.

Given that Aegon changed its managerial view to geographical areas and underlying businesses have developed since 2010, internal management reports have been changed as of 2016 accordingly. Alignment of segment reporting with those changes and developments have been put in place in 2016 reflecting Aegon’s announcements related to its strategic plan. This means that the operating segments as described above have been presented on this basis and introduces separate presentation of the asset management business. The following will be reported from 2016 onwards:

 

t  

Americas: one operating segment which covers business units in the United States, Brazil and Mexico, including any of the units’ activities located outside these countries;

t  

Europe: which covers the following operating segments: the Netherlands, United Kingdom (including VA Europe), Central & Eastern Europe, Spain and Portugal;

t  

Asia: one operating segment which covers businesses operating in Hong Kong, China, Japan, India and Indonesia including any of the units’ activities located outside these countries;

t  

Asset Management: one operating segment which covers business activities from Aegon Asset Management;

t  

Holding and other activities: one operating segment which includes financing, employee and other administrative expenses of holding companies.

For Europe, the underlying businesses (the Netherlands, United Kingdom including VA Europe, Central & Eastern Europe and Spain and Portugal) are separate operating segments which under IFRS 8 cannot be aggregated, therefore further details will be provided for these operating segments.

The change in segment reporting does not have an impact on the financial position, results of operations or cash flows of Aegon.

 

 

Unaudited

   LOGO


Table of Contents

 

       14       

 

 

 

  Condensed Consolidated Interim Financial Statements Q1 2016  

 

 

 

The following table shows the segments as previously reported excluding voluntary changes in accounting policies (as presented in note 2.1):

 

EUR millions   Americas     The
Netherlands
    United
Kingdom
    New
Markets
    Holding and
other
activities
    Eliminations     Segment
Total
    Joint
ventures and
associates
eliminations
    Consolidated  

Three months ended March 31, 2015

                     
     

Underlying earnings before tax geographically

    290        131        38        51        (40     (2     469        3        472   

Fair value items

    (90     151        (22     (4     (193     -        (159     (8     (167

Realized gains / (losses) on investments

    (29     140        2        5        -        -        119        (2     116   

Impairment charges

    (7     (7     -        (2     -        -        (16     -        (16

Impairment reversals

    3        2        -        -        -        -        5        -        5   

Other income / (charges)

    -        (22     21        -        -        -        (1     -        (1

Run-off businesses

    8        -        -        -        -        -        8        -        8   

Income/ (loss) before tax

    175        396        39        50        (233     (2     425        (8     418   

Income tax (expense) / benefit

    (30     (92     (21     (22     57        -        (109     8        (101

Net income/ (loss)

    145        304        18        28        (176     (2     316        -        316   

Inter-segment underlying earnings

    (53     (13     (16     80        3               
     

Revenues

                     

Life insurance gross premiums

    1,693        1,046        1,371        757        -        (24     4,842        (119     4,723   

Accident and health insurance

    552        129        13        60        1        (1     754        (11     743   

General insurance

    -        131        -        63        -        -        194        (19     175   

Total gross premiums

    2,244        1,306        1,383        879        1        (26     5,789        (149     5,641   

Investment income

    908        590        544        117        94        (95     2,158        (61     2,098   

Fee and commission income

    406        85        12        196        -        (68     630        (48     582   

Other revenues

    1        -        -        1        1        -        3        (1     2   

Total revenues

    3,559        1,981        1,939        1,193        97        (188     8,580        (258     8,322   

Inter-segment revenues

    6        -        -        86        96                                   

The following table shows the new segments excluding voluntary changes in accounting policies:

 

EUR millions   Americas     The
Netherlands
    United
Kingdom
    Central &
Eastern
Europe
    Spain &
Portugal
    Europe     Asia     Asset
Management
    Holding and
other
activities
    Eliminations     Segment
total
    Joint
ventures and
associates
eliminations
    Consolidated  

Three months ended March 31, 2015

                             
     

Underlying earnings before tax

    290        131        39        5        3        178        (3     45        (40     (2     469        3        472   

Fair value items

    (90     151        (33     -        -        118        6        -        (193     -        (159     (8     (167

Realized gains / (losses) on investments

    (29     140        2        -        -        142        4        1        -        -        119        (2     116   

Impairment charges

    (7     (7     -        (2     -        (9     -        -        -        -        (16     -        (16

Impairment reversals

    3        2        -        -        -        2        -        -        -        -        5        -        5   

Other income / (charges)

    -        (22     21        -        -        (1     -        -        -        -        (1     -        (1

Run-off businesses

    8        -        -        -        -        -        -        -        -        -        8        -        8   

Income / (loss) before tax

    175        396        29        4        3        431        7        46        (233     (2     425        (8     418   

Income tax (expense) / benefit

    (30     (92     (20     (4     (2     (118     (4     (14     57        -        (109     8        (101

Net income / (loss)

    145        304        9        -        1        313        4        32        (176     (2     316        -        316   

Inter-segment underlying earnings

    (53     (13     (15     (4     -        (32     18        65        3               
     

Revenues

                             

Life insurance gross premiums

    1,693        1,046        1,420        146        49        2,661        512        -        -        (24     4,842        (119     4,723   

Accident and health insurance

    552        129        13        -        25        168        34        -        1        (1     754        (11     743   

General insurance

    -        131        -        44        19        194        -        -        -        -        194        (19     175   

Total gross premiums

    2,244        1,306        1,433        190        94        3,023        546        -        1        (26     5,789        (149     5,641   

Investment income

    908        590        545        12        11        1,158        92        1        96        (96     2,158        (61     2,098   

Fee and commission income

    406        85        25        11        3        124        20        149        -        (70     630        (48     582   

Other revenues

    1        -        -        -        1        1        -        -        1        -        3        (1     2   

Total revenues

    3,559        1,981        2,003        213        108        4,305        658        151        98        (191     8,580        (258     8,322   

Inter-segment revenues

    6        -        -        -        -        -        24        64        97                                   

The following table shows the impact of the voluntary changes in accounting policies (as presented in note 2.1) on the new segments:

 

EUR millions   Americas     The
Netherlands
    United
Kingdom
    Central &
Eastern
Europe
    Spain &
Portugal
    Europe     Asia     Asset
Management
    Holding and
other
activities
    Eliminations     Segment
total
    Joint
ventures and
associates
eliminations
    Consolidated  

Three months ended March 31, 2015

                             
     

Underlying earnings before tax

    -        -        (37     -        -        (37     -        -        -        -        (37     -        (37

Fair value items

    -        -        -        -        -        -        -        -        -        -        -        -        -   

Realized gains / (losses) on investments

    -        -        -        -        -        -        -        -        -        -        -        -        -   

Impairment charges

    -        -        -        -        -        -        -        -        -        -        -        -        -   

Impairment reversals

    -        -        -        -        -        -        -        -        -        -        -        -        -   

Other income / (charges)

    -        -        -        -        -        -        -        -        -        -        -        -        -   

Run-off businesses

    8        -        -        -        -        -        -        -        -        -        8        -        8   

Income / (loss) before tax

    8        -        (37     -        -        (37     -        -        -        -        (29     -        (29

Income tax (expense) / benefit

    (6     -        7        -        -        7        -        -        -        -        2        -        2   

Net income / (loss)

    2        -        (29     -        -        (29     -        -        -        -        (27     -        (27

Inter-segment underlying earnings

    -        -        -        -        -        -        -        -        -               
     

Revenues

                             

Life insurance gross premiums

    -        -        706        -        -        706        -        -        -        -        706        -        706   

Accident and health insurance

    -        -        -        -        -        -        -        -        -        -        -        -        -   

General insurance

    -        -        -        -        -        -        -        -        -        -        -        -        -   

Total gross premiums

    -        -        706        -        -        706        -        -        -        -        706        -        706   

Investment income

    -        -        -        -        -        -        -        -        -        -        -        -        -   

Fee and commission income

    -        -        -        -        -        -        -        -        -        -        -        -        -   

Other revenues

    -        -        -        -        -        -        -        -        -        -        -        -        -   

Total revenues

    -        -        706        -        -        706        -        -        -        -        706        -        706   

Inter-segment revenues

    -        -        -        -        -        -        -        -        -                                   

 

 

LOGO

   Unaudited


Table of Contents
 

 

  Condensed Consolidated Interim Financial Statements Q1 2016  

 

 

 

     15      

 

 

The following table shows the new segment figures taken into account the voluntary changes in accounting policies (as presented in note 2.1):

 

EUR millions   Americas     The
Netherlands
    United
Kingdom
    Central
&
Eastern
Europe
    Spain &
Portugal
    Europe     Asia     Asset
Management
    Holding and
other
activities
    Eliminations     Segment
total
    Joint
ventures and
associates
eliminations
    Consolidated  

Three months ended March 31, 2015

                             
     

Underlying earnings before tax

    290        131        2        5        3        141        (3     45        (40     (2     432        3        435   

Fair value items

    (90     151        (33     -        -        118        6        -        (193     -        (159     (8     (167

Realized gains / (losses) on investments

    (29     140        2        -        -        142        4        1        -        -        119        (2     116   

Impairment charges

    (7     (7     -        (2     -        (9     -        -        -        -        (16     -        (16

Impairment reversals

    3        2        -        -        -        2        -        -        -        -        5        -        5   

Other income / (charges)

    -        (22     21        -        -        (1     -        -        -        -        (1     -        (1

Run-off businesses

    16        -        -        -        -        -        -        -        -        -        16        -        16   

Income / (loss) before tax

    183        396        (8     4        3        394        7        46        (233     (2     396        (8     389   

Income tax (expense) / benefit

    (36     (92     (12     (4     (2     (110     (4     (14     57        -        (107     8        (100

Net income / (loss)

    147        304        (20     -        1        284        4        32        (176     (2     289        -        289   

Inter-segment underlying earnings

    (53     (13     (15     (4     -        (32     18        65        3               
     

Revenues

                             

Life insurance gross premiums

    1,693        1,046        2,126        146        49        3,367        512        -        -        (24     5,547        (119     5,429   

Accident and health insurance

    552        129        13        -        25        168        34        -        1        (1     754        (11     743   

General insurance

    -        131        -        44        19        194        -        -        -        -        194        (19     175   

Total gross premiums

    2,244        1,306        2,139        190        94        3,729        546        -        1        (26     6,495        (149     6,347   

Investment income

    908        590        545        12        11        1,158        92        1        96        (96     2,158        (61     2,098   

Fee and commission income

    406        85        25        11        3        124        20        149        -        (70     630        (48     582   

Other revenues

    1        -        -        -        1        1        -        -        1        -        3        (1     2   

Total revenues

    3,559        1,981        2,709        213        108        5,011        658        151        98        (191     9,286        (258     9,028   

Inter-segment revenues

    6        -        -        -        -        -        24        64        97                                   

Aegon’s segment information is prepared by consolidating on a proportionate basis Aegon’s joint ventures and associated companies.

Performance Measure

A performance measure of reporting segments utilized by the Company is underlying earnings before tax. Underlying earnings before tax reflects Aegon’s profit from underlying business operations and excludes components that relate to accounting mismatches that are dependent on market volatility or relate to events that are considered outside the normal course of business.

Aegon believes that its performance measure, underlying earnings before tax, provides meaningful information about the underlying results of Aegon’s business, including insight into the financial measures that Aegon’s senior management uses in managing the business. Among other things, Aegon’s senior management is compensated based in part on Aegon’s results against targets using underlying earnings before tax. While many other insurers in Aegon’s peer group present substantially similar performance measures, the performance measures presented in this document may nevertheless differ from the performance measures presented by other insurers. There is no standardized meaning to these measures under IFRS or any other recognized set of accounting standards.

The reconciliation from underlying earnings before tax to income before tax, being the most comparable IFRS measure, is presented in the tables in this note.

The items that are excluded from underlying earnings before tax as described further below are: fair value items, realized gain or losses on investments, impairment charges/reversals, other income or charges, run-off businesses and share in earnings of joint ventures and associates.

Fair value items

Fair value items include the over- or underperformance of investments and guarantees held at fair value for which the expected long-term return is included in underlying earnings before tax. Changes to these long-term return assumptions are also included in the fair value items.

 

 

Unaudited

   LOGO


Table of Contents

 

     16       

 

 

 

  Condensed Consolidated Interim Financial Statements Q1 2016  

 

 

 

In addition, hedge ineffectiveness on hedge transactions, fair value changes on economic hedges without natural offset in earnings and for which no hedge accounting is applied and fair value movements on real estate are included under fair value items.

Certain assets held by Aegon are carried at fair value and managed on a total return basis, with no offsetting changes in the valuation of related liabilities. These include assets such as investments in hedge funds, private equities, real estate (limited partnerships), convertible bonds and structured products. Underlying earnings before tax exclude any over- or underperformance compared to management’s long-term expected return on assets. Based on current holdings and asset returns, the long-term expected return on an annual basis is 8-10%, depending on asset class, including cash income and market value changes. The expected earnings from these asset classes are net of deferred policy acquisition costs (DPAC) where applicable.

In addition, certain products offered by Aegon Americas contain guarantees and are reported on a fair value basis and the total return annuities and guarantees on variable annuities. The earnings on these products are impacted by movements in equity markets and risk-free interest rates. Short-term developments in the financial markets may therefore cause volatility in earnings. Included in underlying earnings before tax is a long-term expected return on these products and excluded is any over- or underperformance compared to management’s expected return.

The fair value movements of certain guarantees and the fair value change of derivatives that hedge certain risks on these guarantees of Aegon the Netherlands and VA Europe (included in United Kingdom) are excluded from underlying earnings before tax, and the long-term expected return for these guarantees is set at zero. In addition fair value items include market related results on our loyalty bonus reserves in the United Kingdom. The value of these reserves are directly related to policyholder investments which value is directly impacted by movements in equity and bond markets.

Holding and other activities include certain issued bonds that are held at fair value through profit or loss (FVTPL). The interest rate risk on these bonds is hedged using swaps. The fair value movement resulting from changes in Aegon’s credit spread used in the valuation of these bonds are excluded from underlying earnings before tax and reported under fair value items.

Realized gains or losses on investments

Includes realized gains and losses on available-for-sale investments, mortgage loans and other loan portfolios.

Impairment charges/reversals

Impairment charges include impairments on available-for-sale debt securities, shares including the effect of deferred policyholder acquisition costs, mortgage loans and other loan portfolios at amortized cost, joint ventures and associates. Impairment reversals include reversals on available-for-sale debt securities.

Other income or charges

Other income or charges is used to report any items which cannot be directly allocated to a specific line of business. Also items that are outside the normal course of business are reported under this heading. The impact of model updates used to support calculations of our liabilities for insurance and investment contracts sold to policyholders and related assets are reported under this caption as well.

Other charges may include restructuring charges that are considered other charges for segment reporting purposes because they are outside the normal course of business. In the condensed consolidated interim financial statements, these charges are included in operating expenses.

 

 

LOGO

   Unaudited


Table of Contents
 

 

  Condensed Consolidated Interim Financial Statements Q1 2016  

 

 

 

     17      

 

 

Run-off businesses

Includes underlying results of business units where management has decided to exit the market and to run-off the existing block of business. Currently, this line includes results related to the run-off of the institutional spread-based business, structured settlements blocks of business, bank-owned and corporate-owned life insurance (BOLI/COLI) business, and the sale of the life reinsurance business in the United States. Aegon has other blocks of business for which sales have been discontinued and of which the earnings are included in underlying earnings before tax.

Share in earnings of joint ventures and associates

Earnings from Aegon’s joint ventures in the Netherlands, Mexico, Spain, Portugal, China and Japan and Aegon’s associates in India, Brazil, the Netherlands, United Kingdom, Mexico and France are reported on an underlying earnings before tax basis.

 

 

Unaudited

   LOGO


Table of Contents

 

     18       

 

 

 

  Condensed Consolidated Interim Financial Statements Q1 2016  

 

 

 

3.1 Income statement

 

EUR millions   Americas     The
Netherlands
    United
Kingdom
    Central &
Eastern
Europe
    Spain &
Portugal
    Europe     Asia     Asset
Management
    Holding and
other
activities
    Eliminations     Segment
total
    Joint
ventures and
associates
eliminations
    Consolidated  

Three months ended March 31, 2016

                           
     

Underlying earnings before tax

    283        128        23        15        3        169        -        45        (37     1        462        6        468   

Fair value items

    (220     (105     34        -        -        (71     3        -        (70     -        (358     (13     (370

Realized gains / (losses) on investments

    33        18        1        -        (1     17        4        -        -        -        54        (1     53   

Impairment charges

    (34     (5     -        2        -        (3     (1     -        (4     -        (42     -        (42

Impairment reversals

    2        4        -        -        -        4        -        -        -        -        6        -        6   

Other income / (charges)

    (6     -        1        -        -        1        -        -        -        -        (6     -        (6

Run-off businesses

    28        -        -        -        -        -        -        -        -        -        28        -        28   

Income / (loss) before tax

    87        40        58        16        2        116        6        45        (110     1        145        (7     138   

Income tax (expense) / benefit

    7        (7     (6     (2     (2     (17     (5     (13     26        -        (1     7        6   

Net income / (loss)

    94        33        52        14        -        99        1        32        (84     1        143        -        143   

Inter-segment underlying earnings

    (55     (12     (13     (3     -        (28     21        65        (3          
     

Revenues

                           

Life insurance gross premiums

    1,770        858        2,015        98        49        3,020        299        -        1        (21     5,069        (170     4,899   

Accident and health insurance

    548        121        11        -        72        204        33        -        4        (1     787        (11     775   

General insurance

    -        115        -        47        23        184        -        -        -        -        184        (23     161   

Total gross premiums

    2,318        1,094        2,026        145        144        3,408        331        -        5        (22     6,040        (204     5,836   

Investment income

    916        522        431        11        10        974        57        1        81        (81     1,948        (13     1,935   

Fee and commission income

    418        86        23        9        3        121        14        167        -        (64     656        (54     602   

Other revenues

    1        -        -        -        1        1        -        -        1        -        2        (1     1   

Total revenues

    3,652        1,702        2,480        164        157        4,504        403        168        87        (167     8,646        (272     8,374   

Inter-segment revenues

    -        1        -        -        -        1        20        64        82                                   

 

EUR millions   Americas     The
Netherlands
    United
Kingdom
    Central &
Eastern
Europe
    Spain &
Portugal
    Europe     Asia     Asset
Management
    Holding and
other
activities
    Eliminations     Segment
total
    Joint
ventures and
associates
eliminations
    Consolidated  

Three months ended March 31, 2015

                           
     

Underlying earnings before tax

    290        131        2        5        3        141        (3     45        (40     (2     432        3        435   

Fair value items

    (90     151        (33     -        -        118        6        -        (193     -        (159     (8     (167

Realized gains / (losses) on investments

    (29     140        2        -        -        142        4        1        -        -        119        (2     116   

Impairment charges

    (7     (7     -        (2     -        (9     -        -        -        -        (16     -        (16

Impairment reversals

    3        2        -        -        -        2        -        -        -        -        5        -        5   

Other income / (charges)

    -        (22     21        -        -        (1     -        -        -        -        (1     -        (1

Run-off businesses

    16        -        -        -        -        -        -        -        -        -        16        -        16   

Income / (loss) before tax

    183        396        (8     4        3        394        7        46        (233     (2     396        (8     389   

Income tax (expense) / benefit

    (36     (92     (12     (4     (2     (110     (4     (14     57        -        (107     8        (100

Net income / (loss)

    147        304        (20     -        1        284        4        32        (176     (2     289        -        289   

Inter-segment underlying earnings

    (53     (13     (15     (4     -        (32     18        65        3             
     

Revenues

                           

Life insurance gross premiums

    1,693        1,046        2,126        146        49        3,367        512        -        -        (24     5,547        (119     5,429   

Accident and health insurance

    552        129        13        -        25        168        34        -        1        (1     754        (11     743   

General insurance

    -        131        -        44        19        194        -        -        -        -        194        (19     175   

Total gross premiums

    2,244        1,306        2,139        190        94        3,729        546        -        1        (26     6,495        (149     6,347   

Investment income

    908        590        545        12        11        1,158        92        1        96        (96     2,158        (61     2,098   

Fee and commission income

    406        85        25        11        3        124        20        149        -        (70     630        (48     582   

Other revenues

    1        -        -        -        1        1        -        -        1        -        3        (1     2   

Total revenues

    3,559        1,981        2,709        213        108        5,011        658        151        98        (191     9,286        (258     9,028   

Inter-segment revenues

    6        -        -        -        -        -        24        64        97                                   

 

 

LOGO

   Unaudited


Table of Contents
 

 

  Condensed Consolidated Interim Financial Statements Q1 2016  

 

 

 

     19      

 

 

3.2 Investments

Amounts included in the tables on investments are presented on an IFRS basis.

 

                                                                           EUR millions  
March 31, 2016   Americas     The
Netherlands
    United
Kingdom
    Central &
Eastern
Europe
    Spain &
Portugal
    Europe     Asia     Asset
Management
    Holdings
and other
activities
    Eliminations    

Total

EUR

 
Investments                          
Shares     655        131        470        32        6        639        -        3        115        -        1,411   
Debt securities     66,384        24,496        12,569        566        642        38,273        4,456        -        -        -        109,112   
Loans     9,569        28,529        -        367        59        28,956        18        -        -        -        38,542   
Other financial assets     11,273        355        138        10        -        503        -        51        18        -        11,845   
Investments in real estate     715        1,158        -        2        -        1,160        -        -        -        -        1,874   

Investments general account

    88,595        54,669        13,177        977        707        69,530        4,473        54        133        -        162,784   
Shares     -        8,888        15,479        276        12        24,653        -        -        -        (7     24,647   
Debt securities     4,754        15,264        11,114        250        12        26,641        -        -        -        -        31,395   
Unconsolidated investment funds     91,844        17        35,361        919        56        36,353        -        -        -        -        128,197   
Other financial assets     13        3,135        3,127        16        -        6,278        -        -        -        -        6,290   
Investments in real estate     -        -        758        -        -        758        -        -        -        -        758   
Investments for account of policyholders     96,611        27,303        65,837        1,461        81        94,682        -        -        -        (7     191,286   
     
Investments on balance sheet     185,206        81,973        79,014        2,438        788        164,212        4,473        54        133        (7     354,070   
Off balance sheet investments third parties     213,627        874        3,990        2,967        512        8,342        2,357        209,822        -        (83,665     350,483   
Total revenue generating investments     398,833        82,846        83,003        5,405        1,299        172,554        6,830        209,876        133        (83,672     704,554   
Investments                          
Available-for-sale     74,631        23,570        12,883        589        648        37,691        4,437        44        18        -        116,821   
Loans     9,569        28,529        -        367        59        28,956        18        -        -        -        38,542   
Financial assets at fair value through profit or loss     100,292        28,715        65,373        1,479        81        95,648        19        9        115        (7     196,076   
Investments in real estate     715        1,158        758        2        -        1,917        -        -        -        -        2,632   
Total investments on balance sheet     185,206        81,973        79,014        2,438        788        164,212        4,473        54        133        (7     354,070   
     
Investments in joint ventures     6        789        -        -        515        1,305        132        114        1        -        1,558   
Investments in associates     80        20        8        -        -        28        16        128        -        -        252   
Other assets     26,601        22,348        5,958        299        294        28,885        2,735        290        33,698        (33,501     58,722   
Consolidated total assets     211,893        105,130        84,980        2,737        1,597        194,430        7,355        586        33,832        (33,508     414,602   

 

                                                                           EUR millions  
December 31, 2015   Americas     The
Netherlands
    United
Kingdom
    Central &
Eastern
Europe
    Spain &
Portugal
    Europe     Asia     Asset
Management
    Holdings
and other
activities
    Eliminations    

Total

EUR

 
Investments                          
Shares     652        136        506        38        2        682        -        2        124        -        1,460   
Debt securities     65,284        23,370        13,185        525        636        37,715        4,391        -        -        -        107,390   
Loans     10,062        28,007        -        340        62        28,409        19        -        88        -        38,577   
Other financial assets     10,783        335        160        6        2        503        -        72        18        -        11,376   
Investments in real estate     840        1,148        -        2        -        1,150        -        -        -        -        1,990   
Investments general account     87,620        52,996        13,850        911        702        68,459        4,409        74        230        -        160,792   
Shares     -        9,174        17,274        247        12        26,707        -        -        -        (8     26,699   
Debt securities     4,967        14,642        11,728        256        13        26,640        -        -        -        -        31,606   
Unconsolidated investment funds     96,187        17        37,622        959        61        38,658        -        -        -        -        134,845   
Other financial assets     10        2,923        3,115        6        1        6,044        -        -        -        -        6,054   
Investments in real estate     -        -        1,022        -        -        1,022        -        -        -        -        1,022   
Investments for account of policyholders     101,164        26,756        70,760        1,468        87        99,070        -        -        -        (8     200,226   
     
Investments on balance sheet     188,784        79,752        84,610        2,379        789        167,529        4,409        74        230        (8     361,019   
Off balance sheet investments third parties     212,704        897        3,899        2,855        508        8,158        2,317        213,320        -        (87,059     349,440   
Total revenue generating investments     401,487        80,648        88,509        5,234        1,297        175,687        6,727        213,394        230        (87,067     710,458   
Investments                          
Available-for-sale     72,761        22,479        13,534        545        638        37,195        4,370        65        18        -        114,409   
Loans     10,062        28,007        -        340        62        28,409        19        -        88        -        38,577   
Financial assets at fair value through profit or loss     105,121        28,119        70,054        1,493        88        99,753        21        9        124        (8     205,020   
Investments in real estate     840        1,148        1,022        2        -        2,171        -        -        -        -        3,012   
Total investments on balance sheet     188,784        79,752        84,610        2,379        789        167,529        4,409        74        230        (8     361,019   
     
Investments in joint ventures     7        837        -        -        505        1,341        101        109        3        -        1,561   
Investments in associates     75        19        9        -        -        28        12        126        -        -        242   
Other assets     27,396        17,349        5,204        322        124        22,984        3,070        304        31,020        (31,881     52,908   
Consolidated total assets     216,262        97,956        89,822        2,701        1,417        191,882        7,592        613        31,254        (31,889     415,729   

 

 

 

Unaudited

   LOGO


Table of Contents

 

     20       

 

 

 

  Condensed Consolidated Interim Financial Statements Q1 2016  

 

 

 

4. Premium income

 

                

EUR millions

    Q1 2016        Q1 2015   
   

Premium income

     

Life

    4,899        5,429   

Non-Life

    937        918   

Total

    5,836        6,347   
   

Premiums paid to reinsurers 1

     

Life

    646        620   

Non-Life

    67        69   

Total

    713        689   

1 Premiums paid to reinsurers are recorded within Benefits and expenses in the income statement - refer to note 7 - Benefits and expenses.

Premium income Life includes EUR 802 million (Q1 2015: EUR 849 million of premiums related to insurance policies upgraded to the new retirement platform in the UK.

5. Investment income

 

                

EUR millions

    Q1 2016        Q1 2015   
   

Interest income

    1,707        1,762   

Dividend income

    194        301   

Rental income

    34        35   

Total investment income

    1,935        2,098   
   

Investment income related to general account

    1,493        1,504   

Investment income for account of policyholders

    442        594   

Total

    1,935        2,098   

6. Results from financial transactions

 

                

EUR millions

    Q1 2016        Q1 2015   
   

Net fair value change of general account financial investments at FVTPL other than derivatives

    (72     71   

Realized gains /(losses) on financial investments

    53        136   

Gains /(losses) on investments in real estate

    18        10   

Net fair value change of derivatives

    438        1,407   

Net fair value change on for account of policyholder financial assets at FVTPL

    1,596        8,300   

Net fair value change on investments in real estate for account of policyholders

    8        7   

Net foreign currency gains /(losses)

    17        (22

Net fair value change on borrowings and other financial liabilities

    (9     (6

Total

    2,050        9,905   

The decrease of the net fair value change on for account of policyholder financial assets at FVTPL in Q1 2016 compared to Q1 2015 is mainly driven by equity markets and interest rates movements.

Net fair value change on for accounts of policyholder financial assets at FVTPL is offset by amounts in the Claims and benefits line reported in note 7 - Benefits and expenses.

 

LOGO    Unaudited


Table of Contents
 

 

  Condensed Consolidated Interim Financial Statements Q1 2016  

 

 

 

     21      

 

 

7. Benefits and expenses

 

                

EUR millions

    Q1 2016        Q1 2015   
   

Claims and benefits

    10,041        18,338   

Employee expenses

    596        562   

Administration expenses

    311        297   

Deferred expenses

    (323     (413

Amortization charges

    277        343   

Total

    10,901        19,127   

The following table provides an analysis of “claims and benefits”:

 

                

EUR millions

    Q1 2016        Q1 2015   
   

Benefits and claims paid life

    4,711        5,778   

Benefits and claims paid non-life

    538        514   

Change in valuation of liabilities for insurance contracts

    3,000        10,095   

Change in valuation of liabilities for investment contracts

    284        408   

Other

    (5     (21

Policyholder claims and benefits

    8,527        16,774   

Premium paid to reinsurers

    713        689   

Profit sharing and rebates

    7        8   

Commissions

    795        867   

Total

    10,041        18,338   

The lines “change in valuation of liabilities for insurance contracts” and “change in valuation of liabilities for investment contracts” reflect changes in technical provisions resulting from fair value changes on for account of policyholder financial assets included in Results from financial transactions (note 6) of EUR 1,596 (2015 Q1: EUR 8,300). In addition, the line “change in valuation of liabilities for insurance contracts” includes changes in technical provisions for life insurance contracts of EUR 1,863 (2015 Q1: EUR 2,846).

 

 

Unaudited

   LOGO


Table of Contents

 

     22       

 

 

 

  Condensed Consolidated Interim Financial Statements Q1 2016  

 

 

 

8. Impairment charges/(reversals)

 

                

EUR millions

    Q1 2016        Q1 2015   
   

Impairment charges / (reversals) comprise:

     

Impairment charges on financial assets, excluding receivables 1

    41        18   

Impairment reversals on financial assets, excluding receivables 1

    (6     (5

Impact of the above impairments on the valuation of insurance assets and liabilities 1

    4        -   

Impairment charges / (reversals) on non-financial assets and receivables

    1        -   

Total

    40        13   
   

Impairment charges on financial assets, excluding receivables, from:

     

Shares

    10        2   

Debt securities and money market instruments

    28        3   

Loans

    3        12   

Total

    41        18   
   

Impairment reversals on financial assets, excluding receivables, from:

     

Debt securities and money market instruments

    (3     (3

Loans

    (4     (2

Total

    (6     (5

1 Impairment charges / (reversals) on financial assets, excluding receivables, are excluded from underlying earnings before tax for segment reporting (refer to note 3.1).

9. Intangible assets

 

                

EUR millions

    Mar. 31, 2016        Dec. 31, 2015   
   

Goodwill

    276        299   

VOBA

    1,403        1,472   

Future servicing rights

    65        57   

Software

    59        61   

Other

    12        12   

Total intangible assets

    1,815        1,901   

Intangible assets, except for goodwill, are predominantly impacted by periodic amortization of balances and changes in exchange rates.

10. Investments

 

                

EUR millions

    Mar. 31, 2016        Dec. 31, 2015   
   

Available-for-sale (AFS)

    116,821        114,409   

Loans

    38,542        38,577   

Financial assets at fair value through profit or loss (FVTPL)

    5,547        5,816   

Financial assets, for general account, excluding derivatives

    160,910        158,803   

Investments in real estate

    1,874        1,990   

Total investments for general account, excluding derivatives

    162,784        160,792   

 

 

LOGO

  

Unaudited


Table of Contents
 

 

  Condensed Consolidated Interim Financial Statements Q1 2016  

 

 

 

     23      

 

 

         

Financial assets, for general account, excluding derivatives

 

                               
   
EUR millions   AFS     FVTPL     Loans     Total  
   

Shares

    821        589        -        1,411   

Debt securities

    106,876        2,236        -        109,112   

Money market and other short-term investments

    7,882        321        -        8,203   

Mortgages loans

    -        -        33,192        33,192   

Private loans

    -        -        2,947        2,947   

Deposits with financial institutions

    -        -        207        207   

Policy loans

    -        -        2,079        2,079   

Other

    1,242        2,401        117        3,760   

March 31, 2016

    116,821        5,547        38,542        160,910   
   
      AFS        FVTPL        Loans        Total   
   

Shares

    820        640        -        1,460   

Debt securities

    105,151        2,239        -        107,390   

Money market and other short-term investments

    7,141        303        -        7,444   

Mortgages loans

    -        -        33,214        33,214   

Private loans

    -        -        2,847        2,847   

Deposits with financial institutions

    -        -        106        106   

Policy loans

    -        -        2,201        2,201   

Other

    1,297        2,635        210        4,141   

December 31, 2015

    114,409        5,816        38,577        158,803   

11. Investments for account of policyholders

 

                

EUR millions

    Mar. 31, 2016        Dec. 31, 2015   

Shares

    24,647        26,699   

Debt securities

    31,395        31,606   

Money market and short-term investments

    1,595        1,907   

Deposits with financial institutions

    1,555        1,222   

Unconsolidated investment funds

    128,197        134,845   

Other

    3,140        2,925   

Total investments for account of policyholders at fair value through profit or loss, excluding derivatives

    190,529        199,204   

Investment in real estate

    758        1,022   

Total investments for account of policyholders

    191,286        200,226   

12. Derivatives

The movements in derivative balances mainly result from changes in interest rates during the period as well as purchases and disposals.

 

 

Unaudited

   LOGO


Table of Contents

 

     24       

 

 

 

  Condensed Consolidated Interim Financial Statements Q1 2016  

 

 

 

13. Fair value

The following tables provide an analysis of financial instruments recorded at fair value on a recurring basis by level of the fair value hierarchy:

 

Fair value hierarchy                            
EUR millions   Level I     Level II     Level III     Total  

As at March 31, 2016

         
   

Financial assets carried at fair value

         

Available-for-sale investments

         

Shares

    30        477        314        821   

Debt securities

    31,068        72,375        3,432        106,876   

Money markets and other short-term instruments

    -        7,882        -        7,882   

Other investments at fair value

    26        358        858        1,242   

Total Available-for-sale investments

    31,125        81,092        4,604        116,821   
   

Fair value through profit or loss

         

Shares

    225        364        -        589   

Debt securities

    18        2,212        6        2,236   

Money markets and other short-term instruments

    -        321        -        321   

Other investments at fair value

    1        1,308        1,091        2,401   

Investments for account of policyholders 1

    115,761        73,178        1,590        190,529   

Derivatives

    19        16,861        409        17,288   

Total Fair value through profit or loss

    116,024        94,244        3,095        213,364   

Total financial assets at fair value

    147,149        175,337        7,699        330,185   
   

Financial liabilities carried at fair value

         

Investment contracts for account of policyholders 2

    16,391        22,376        131        38,899   

Borrowings 3

    -        600        -        600   

Derivatives

    (17     13,327        3,158        16,468   

Total financial liabilities at fair value

    16,374        36,304        3,289        55,967   
       
Fair value hierarchy                            
EUR millions   Level I     Level II     Level III     Total  

As at December 31, 2015

         
   

Financial assets carried at fair value

         

Available-for-sale investments

         

Shares

    29        498        293        820   

Debt securities

    28,701        72,307        4,144        105,151   

Money markets and other short-term instruments

    -        7,141        -        7,141   

Other investments at fair value

    31        337        928        1,297   

Total Available-for-sale investments

    28,761        80,283        5,365        114,409   
   

Fair value through profit or loss

         

Shares

    254        385        -        640   

Debt securities

    16        2,217        6        2,239   

Money markets and other short-term instruments

    -        303        -        303   

Other investments at fair value

    2        1,368        1,265        2,635   

Investments for account of policyholders 1

    121,227        76,232        1,745        199,204   

Derivatives

    54        11,270        222        11,545   

Total Fair value through profit or loss

    121,552        91,775        3,239        216,566   

Total financial assets at fair value

    150,313        172,058        8,604        330,975   
   

Financial liabilities carried at fair value

         

Investment contracts for account of policyholders 2

    16,943        23,266        156        40,365   

Borrowings 3

    -        617        -        617   

Derivatives

    4        8,782        2,104        10,890   

Total financial liabilities at fair value

    16,946        32,665        2,260        51,871   

 

1 

The investments for account of policyholders included in the table above represents only those investments carried at fair value through profit or loss.

2 

The investment contracts for account of policyholders included in the table above represents only those investment contracts carried at fair value.

3 

Total borrowings on the statement of financial position contain borrowings carried at amortized cost that are not included in the above schedule.

 

 

LOGO

   Unaudited


Table of Contents
 

 

  Condensed Consolidated Interim Financial Statements Q1 2016  

 

 

 

     25      

 

 

Significant transfers between Level I, Level II and Level III

Aegon’s policy is to record transfers of assets and liabilities between Level I, Level II and Level III at their fair values as of the beginning of each reporting period.

The table below shows transfers between Level I and II for financial assets and financial liabilities recorded at fair value on a recurring basis during the three month period ended March 31, 2016.

 

Fair value transfers                            
EUR millions   Q1 2016     Full Year 2015  
     Transfers
Level I to
Level II
    Transfers
Level II to
Level I
    Transfers
Level I to
Level II
    Transfers
Level II
to Level I
 

Financial assets carried at fair value

         

Available-for-sale investments

         

Debt securities

    1        2        14        156   

Total

    1        2        14        156   
     

Fair value through profit or loss

         

Shares

    -        -        -        40   

Investments for account of policyholders

    -        2        (3     209   

Total

    -        2        (3     248   

Total financial assets at fair value

    1        4        11        405   

Financial liabilities carried at fair value

         

Investment contracts for account of policyholders

    -        -        -        1   

Total financial liabilities at fair value

    -        -        -        1   

Transfers are identified based on transaction volume and frequency, which are indicative of an active market.

Movements in Level III financial instruments measured at fair value

The following table summarizes the change of all assets and liabilities measured at estimated fair value on a recurring basis using significant unobservable inputs (‘Level III’), including realized and unrealized gains (losses) of all assets and liabilities and unrealized gains (losses) of all assets and liabilities still held at the end of the respective period.

 

Roll forward of Level III financial instruments                                            
EUR millions   January 1,
2016
    Total gains /
losses in
income
statement 1
    Total gains /
losses in OCI 2
    Purchases     Sales     Settlements     Net exchange
differences
    Reclassification     Transfers from
Level I and
Level II
    Transfers to
Level I and
Level II
    March 31,
2016
    Total unrealized
gains and losses
for the  period
recorded in the
P&L for
instruments
held at
March 31, 2016 ³
 

Financial assets carried at fair value available-for-sale investments

                         

Shares

    293        3        (1     44        (17     -        (8     -        -        -        314        -   

Debt securities

    4,144        5        11        61        (37     (75     (71     -        82        (688     3,432        -   

Other investments at fair value

    928        (25     17        43        (62     (1     (43     -        -        -        858        -   
      5,365        (18     28        149        (117     (75     (122     -        82        (688     4,604        -   
   

Fair value through profit or loss

                         

Debt securities

    6        -        -        -        -        -        -        -        -        -        6        -   

Other investments at fair value

    1,265        (39     -        16        (32     -        (55     -        93        (157     1,091        (36

Investments for account of policyholders

    1,745        (58     -        105        (138     -        (28     -        -        (36     1,590        (60

Derivatives

    222        (2     -        -        240        -        (15     (36     -        -        409        (1
      3,239        (100     -        121        70        -        (98     (36     93        (193     3,095        (97
   

Financial liabilities carried at fair value

                         

Investment contracts for account of policyholders

    156        (19     -        3        (2     -        (5     -        -        (2     131        (18

Derivatives

    2,104        1,303        -        -        (160     -        (53     (36     -        -        3,158        1,238   
      2,260        1,284        -        3        (162     -        (57     (36     -        (2     3,289        1,219   

 

 

Unaudited

   LOGO


Table of Contents

 

     26       

 

 

 

  Condensed Consolidated Interim Financial Statements Q1 2016  

 

 

 

 

EUR
millions
  January 1,
2015
    Total gains /
losses in
income
statement 1
    Total gains /
losses in OCI 2
    Purchases     Sales     Settlements     Net exchange
differences
    Reclassification     Transfers from
Level I and
Level II
    Transfers to
Level I and
Level II
    December 31,
2015
   

Total unrealized
gains and losses

for the period
recorded in the

P&L for

instruments

held at
December 31, 2015 ³

 

Financial assets carried at fair value available-for-sale investments

                           

Shares

    280        32        30        92        (124     (33     16        -        -        -        293        -   

Debt securities

    3,803        (2     29        842        (367     (198     212        -        182        (359     4,144        -   

Other investments at fair value

    934        (206     9        179        (72     (18     102        -        -        -        928        -   
      5,018        (176     69        1,113        (563     (249     330        -        182        (359     5,365        -   

Fair value through profit or loss

                           

Debt securities

    17        -        -        -        (2     -        2        -        -        (9     6        -   

Other investments at fair value

    1,237        (20     -        179        (397     -        139        -        291        (162     1,265        17   

Investments for account of policyholders

    1,956        126        -        486        (773     -        33        -        -        (83     1,745        85   

Derivatives

    320        (173     -        12        48        -        15        -        -        -        222        (176
      3,530        (67     -        677        (1,124     -        188        -        291        (255     3,239        (74

Financial liabilities carried at fair value

                           

Investment contracts for account of policyholders

    165        3        -        12        (34     -        14        -        -        (5     156        3   

Derivatives

    3,010        (925     -        -        (98     -        116        -        -        -        2,104        (972
      3,175        (922     -        13        (131     -        131        -        -        (5     2,260        (969

1 Includes impairments and movements related to fair value hedges. Gains and losses are recorded in the line item results from financial transactions of the income statement.

2 Total gains and losses are recorded in line items Gains/ (losses) on revaluation of available-for-sale investments and (Gains)/ losses transferred to the income statement on disposal and impairment of available-for-sale investment of the statement of other comprehensive income.

3 Total gains / (losses) for the period during which the financial instrument was in Level III.

During the first three months of 2016, Aegon transferred certain financial instruments from Level II to Level III of the fair value hierarchy. The reason for the change in level was that the market liquidity for these securities decreased, which led to a change in market observability of prices. Prior to transfer, the fair value for the Level II securities was determined using observable market transactions or corroborated broker quotes respectively for the same or similar instruments. The amount of assets and liabilities transferred to Level III was EUR 175 million (full year 2015: EUR 473 million). Since the transfer, all such assets have been valued using valuation models incorporating significant non market-observable inputs or uncorroborated broker quotes.

Similarly, during the first three months of 2016, Aegon transferred EUR 883 million (full year 2015: EUR 619 million) of financial instruments from Level III to other levels of the fair value hierarchy. The change in level was mainly the result of a return of activity in the market for these securities and that for these securities the fair value could be determined using observable market transactions or corroborated broker quotes for the same or similar instruments.

 

 

LOGO

   Unaudited


Table of Contents
 

 

  Condensed Consolidated Interim Financial Statements Q1 2016  

 

 

 

     27      

 

 

The table below presents information about the significant unobservable inputs used for recurring fair value measurements for certain Level III financial instruments.

 

Overview of significant unobservable inputs              
EUR millions   Carrying
amount March 31,
2016
    Valuation technique 1         Significant unobservable
input 2
        Range (weighted  average)

Financial assets carried at fair value available-for-sale investments

         

Shares

    161        Net asset value        n.a.      n.a.
      153        Other        n.a.      n.a.
      314                       
   

Debt securities

         
      2,909        Broker quote        n.a.      n.a.
      200        Discounted cash flow        Credit spread      1.58% - 4.44% (3.20%)
      324        Other        n.a.      n.a.
      3,432                       

Other investments at fair value

         

Tax credit investments

    749        Discounted cash flow        Discount rate      6.9%

Investment funds

    69        Net asset value        n.a.      n.a.

Other

    40        Other        n.a.      n.a.

March 31, 2016

    858                       
   

Fair value through profit or loss

         

Debt securities

    6        Other        n.a.      n.a.
      6                       
   

Other investments at fair value

         

Investment funds

    1,085        Net asset value        n.a.      n.a.

Other

    5        Other        n.a.      n.a.
      1,091                       
   

Derivatives 3

         

Longevity swap

    109        Discounted cash flow        Mortality       

Other

    165        Other        n.a.      n.a.

March 31, 2016

    274                       
   

Financial liabilities carried at fair value

         

Derivatives

         

Embedded derivatives in insurance contracts

    3,150        Discounted cash flow        Own Credit spread      0.40% - 0.55% (0.46%)

Other

    8        Other        n.a.      n.a.

Total financial liabilities at fair value

    3,158                       
1 

Other in the table above (column Valuation technique) includes investments for which the fair value is uncorroborated and no broker quote is received.

2 

Not applicable (n.a.) has been included when no significant unobservable assumption has been identified and used.

3 

Investments for account of policyholders are excluded from the table above and from the disclosure regarding reasonably possible alternative assumptions. Policyholder assets, and their returns, belong to policyholders and do not impact Aegon’s net income or equity. The effect on total assets is offset by the effect on total liabilities. Derivatives exclude derivatives for account of policyholders amounting to EUR 135 million.

The description of Aegon’s methods of determining fair value is included in the consolidated financial statements for 2015. For reference purposes, the valuation techniques included in the table above are described in more detail on the following pages.

Shares

When available, Aegon uses quoted market prices in active markets to determine the fair value of its investments in shares. Fair values for unquoted shares are estimated using observations of the price/earnings or price/cash flow ratios of quoted companies considered comparable to the companies being valued. Valuations are adjusted to account for company-specific issues and the lack of liquidity inherent in an unquoted investment. Adjustments for illiquidity are generally based on available market evidence. In addition, a variety of other factors are reviewed by management, including, but not limited to, current operating performance, changes in market outlook and the third-party financing environment.

Available-for-sale shares include shares in a Federal Home Loan Bank (FHLB) for an amount of EUR 148 million (December 31, 2015: EUR 120 million) that are measured at par, which are reported as part of Other in the column Valuation technique. A FHLB has implicit financial support from the United States government. The redemption value of the shares is fixed at par and they can only be redeemed by the FHLB.

 

 

 

Unaudited

   LOGO


Table of Contents

 

     28       

 

 

 

  Condensed Consolidated Interim Financial Statements Q1 2016  

 

 

 

Debt securities

Aegon’s portfolio of debt securities can be subdivided in Residential mortgage-backed securities (RMBS), Commercial mortgage-backed securities (CMBS), Asset-backed securities (ABS), Corporate bonds and Sovereign debt. Below relevant details in the valuation methodology for these specific types of debt securities are described.

Valuations of RMBS, CMBS and ABS are monitored and reviewed on a monthly basis. Valuations per asset type are based on a pricing hierarchy which uses a waterfall approach that starts with market prices from indices and follows with third-party pricing services or brokers. The pricing hierarchy is dependent on the possibilities of corroboration of the market prices. If no market prices are available, Aegon uses internal models to determine fair value. Significant inputs included in the internal models are generally determined based on relative value analyses, which incorporate comparisons to instruments with similar collateral and risk profiles. Market standard models may be used to model the specific collateral composition and cash flow structure of each transaction.

Valuations of corporate bonds are monitored and reviewed on a monthly basis. The pricing hierarchy is dependent on the possibility of corroboration of market prices when available. If no market prices are available, valuations are determined by a discounted cash flow methodology using an internally calculated yield. The yield is comprised of a credit spread over a given benchmark. In all cases, the benchmark is an observable input. The credit spread contains both observable and unobservable inputs. Aegon starts by taking an observable credit spread from a similar bond of the given issuer, and then adjusts this spread based on unobservable inputs. These unobservable inputs may include subordination, liquidity and maturity differences. The weighted average credit spread used in valuation of corporate bonds has increased to 3.20% (December 31, 2015: 2.84%).

If available, Aegon uses quoted market prices in active markets to determine the fair value of its sovereign debt investments. If Aegon cannot make use of quoted market prices, market prices from indices or quotes from third-party pricing services or brokers are used.

Tax credit investments

The fair value of tax credit investments is determined by using a discounted cash flow valuation technique. This valuation technique takes into consideration projections of future capital contributions and distributions, as well as future tax credits and the tax benefits of future operating losses. The present value of these cash flows is calculated by applying a discount rate. In general, the discount rate is determined based on the cash outflows for the investments and the cash inflows from the tax credits/tax benefits (and the timing of those cash flows). These inputs are unobservable in the market place. The discount rate used in valuation of tax credit investments has decreased to 6.9% (December 31, 2015: 7.4%).

Investment funds

Investment funds include real estate funds, private equity funds and hedge funds. The fair values of investments held in non-quoted investment funds are determined by management after taking into consideration information provided by the fund managers. Aegon reviews the valuations each month and performs analytical procedures and trending analyses to ensure the fair values are appropriate.

Derivatives

Where quoted market prices are not available, other valuation techniques, such as option pricing or stochastic modeling, are applied. The valuation techniques incorporate all factors that a typical market participant would consider and are based on observable market data when available. Models are validated before they are used and calibrated to ensure that outputs reflect actual experience and comparable market prices.

 

 

LOGO

   Unaudited


Table of Contents
 

 

  Condensed Consolidated Interim Financial Statements Q1 2016  

 

 

 

     29      

 

 

Fair values for exchange-traded derivatives, principally futures and certain options, are based on quoted market prices in active markets. Fair values for over-the-counter (OTC) derivatives represent amounts estimated to be received from or paid to a third party in settlement of these instruments. These derivatives are valued using pricing models based on the net present value of estimated future cash flows, directly observed prices from exchange-traded derivatives, other OTC trades, or external pricing services. Most valuations are derived from swap and volatility matrices, which are constructed for applicable indices and currencies using current market data from many industry standard sources. Option pricing is based on industry standard valuation models and current market levels, where applicable. The pricing of complex or illiquid instruments is based on internal models or an independent third party. For long-dated illiquid contracts, extrapolation methods are applied to observed market data in order to estimate inputs and assumptions that are not directly observable. To value OTC derivatives, management uses observed market information, other trades in the market and dealer prices.

Some OTC derivatives are so-called longevity derivatives. The payout of longevity derivatives is linked to publicly available mortality tables. The derivatives are measured using the present value of the best estimate of expected payouts of the derivative plus a risk margin. The best estimate of expected payouts is determined using best estimate of mortality developments. Aegon determined the risk margin by stressing the best estimate mortality developments to quantify the risk and applying a cost-of-capital methodology. The most significant unobservable input for these derivatives is the (projected) mortality development.

Aegon normally mitigates counterparty credit risk in derivative contracts by entering into collateral agreements where practical and in ISDA master netting agreements for each of the Group’s legal entities to facilitate Aegon’s right to offset credit risk exposure. Changes in the fair value of derivatives attributable to changes in counterparty credit risk were not significant.

Embedded derivatives in insurance contracts including guarantees

All bifurcated guarantees for minimum benefits in insurance and investment contracts are carried at fair value. These guarantees include guaranteed minimum withdrawal benefits (GMWB) in the United States, United Kingdom and Japan which are offered on some variable annuity products and are also assumed from a ceding company; minimum investment return guarantees on insurance products offered in the Netherlands, including group pension and traditional products; variable annuities sold in Europe and Japan.

Since the price of these guarantees is not quoted in any market, the fair values of these guarantees are based on discounted cash flows calculated as the present value of future expected payments to policyholders less the present value of assessed rider fees attributable to the guarantees. Given the complexity and long-term nature of these guarantees which are unlike instruments available in financial markets, their fair values are determined by using stochastic models under a variety of market return scenarios. A variety of factors are considered including credit spread, expected market rates of return, equity and interest rate volatility, correlations of market returns, discount rates and actuarial assumptions. The most significant unobservable factor is credit spread. The credit spread used in the valuations of embedded derivatives in insurance contracts increased to 0.46% (December 31, 2015: 0.33%).

The expected returns are based on risk-free rates. Aegon added a premium to reflect the credit spread as required. The credit spread is set by using the credit default swap (CDS) spreads of a reference portfolio of life insurance companies (including Aegon), adjusted to reflect the subordination of senior debt holders at the holding company level to the position of policyholders at the operating company level (who have priority in payments to other creditors). Aegon’s assumptions are set by region to reflect differences in the valuation of the guarantee embedded in the insurance contracts.

Since many of the assumptions are unobservable and are considered to be significant inputs to the liability valuation, the liability included in future policy benefits has been reflected within Level III of the fair value hierarchy.

 

 

Unaudited

   LOGO


Table of Contents

 

     30       

 

 

 

  Condensed Consolidated Interim Financial Statements Q1 2016  

 

 

 

Effect of reasonably possible alternative assumptions

The effect of changes in other unobservable inputs on fair value measurement were not significantly different than those that were applied to the consolidated financial statements as at and for the year ended December 31, 2015.

Fair value information about financial instruments not measured at fair value

The following table presents the carrying values and estimated fair values of financial assets and liabilities, excluding financial instruments which are carried at fair value on a recurring basis.

 

Fair value information about financial instruments not measured at fair value

 

 
EUR millions   Carrying
amount
March 31,
2016
    Total
estimated fair
value March 31,
2016
    Carrying
amount
December 31,
2015
   

Total
estimated fair
value

December 31,
2015

 
     

Assets

           

Mortgage loans - held at amortized cost

    33,192        37,951        33,214        37,648   

Private loans - held at amortized cost

    2,947        3,369        2,847        3,165   

Other loans - held at amortized cost

    2,403        2,403        2,517        2,517   
     

Liabilities

           

Trust pass-through securities - held at amortized cost

    153        140        157        146   

Subordinated borrowings - held at amortized cost

    757        836        759        828   

Borrowings – held at amortized cost

    10,205        10,632        11,829        12,194   

Investment contracts - held at amortized cost

    17,590        18,148        17,260        17,860   

Financial instruments for which carrying value approximates fair value

Certain financial instruments that are not carried at fair value are carried at amounts that approximate fair value, due to their short-term nature and generally negligible credit risk. These instruments include cash and cash equivalents, short-term receivables and accrued interest receivable, short-term liabilities, and accrued liabilities. These instruments are not included in the table above.

14. Deferred expenses

 

                

EUR millions

    Mar. 31, 2016        Dec. 31, 2015   
     

DPAC for insurance contracts and investment contracts with discretionary participation features

    9,781        10,457   

Deferred cost of reinsurance

    70        72   

Deferred transaction costs for investment management services

    448        467   

Total deferred expenses

    10,299        10,997   

15. Share capital

 

                

EUR millions

    Mar. 31, 2016        Dec. 31, 2015   
     

Share capital - par value

    328        328   

Share premium

    8,059        8,059   

Total share capital

    8,387        8,387   
     

Share capital - par value

       

Balance at January 1

    328        327   

Issuance

    -        -   

Share dividend

    -        -   

Balance

    328        328   
     

Share premium

       

Balance at January 1

    8,059        8,270   

Share dividend

    -        (211

Balance

    8,059        8,059   

 

 

LOGO

   Unaudited


Table of Contents
 

 

  Condensed Consolidated Interim Financial Statements Q1 2016  

 

 

 

     31      

 

 

Basic and diluted earnings per share

 

                

EUR millions

    Q1 2016        Q1 2015   
   

Earnings per share (EUR per share)

     

Basic earnings per common share

    0.05        0.12   

Basic earnings per common share B

    -        -   

Diluted earnings per common share

    0.05        0.12   

Diluted earnings per common share B

    -        -   
   

Earnings per share calculation

     

Net income / (loss) attributable to equity holders of Aegon N.V.

    143        289   

Coupons on other equity instruments

    (35     (36

Earnings attributable to common shares and common shares B

    109        253   
   

Earnings attributable to common shareholders

    108        251   

Earnings attributable to common shareholders B

    1        2   
   

Weighted average number of common shares outstanding (in millions)

    2,084        2,095   

Weighted average number of common shares B outstanding (in millions)

    585        581   

Dividend

Aegon will propose to the Annual General Meeting of Shareholders on May 20, 2016, absent unforeseen circumstances, to pay a final dividend for the year 2015 of EUR 0.13 per common share. After taking into account the interim dividend 2015 of EUR 0.12 per common share, this will result in a total 2015 dividend of EUR 0.25 per common share. Proposed final dividend for the year and proposed total 2015 dividend per common share B amount to 1/40th of the dividend paid on common shares.

Share buy back

As announced on January 13, 2016, during an update on Aegon’s strategic plans at its Analyst & Investor Conference, Aegon executed the first tranche of a share buyback program in which 41,082,683 common shares were repurchased. Between January 13, 2016 and March 31, 2016, these common shares were repurchased at an average price of EUR 4.8682 per share. It will be proposed to shareholders at the Annual General Meeting of Shareholders on May 20, 2016, to cancel all repurchased shares under this program. These common shares are being repurchased as part of a program to neutralize the dilutive effect of the cancellation of the preferred shares in 2013.

16. Borrowings

 

                
EUR millions   Mar. 31, 2016     Dec. 31, 2015  
     

Capital funding

    1,936        2,015   

Operational funding

    8,869        10,430   

Total borrowings

    10,806        12,445   

Included in borrowings is EUR 600 million relating to borrowings measured at fair value (December 31, 2015: EUR 617 million).

Operational funding

During Q1 2016, Aegon redeemed EUR 450 million of ECB LTRO and repurchased the mortgage loans from SAECURE 9 and SAECURE 10 for EUR 1,658 million. In addition, Aegon entered into a USD 975 million new liquidity program from the Federal Home Loan Bank.

 

 

Unaudited

   LOGO


Table of Contents

 

     32       

 

 

 

  Condensed Consolidated Interim Financial Statements Q1 2016  

 

 

 

17. Commitments and contingencies

There have been no material changes in contingent assets and liabilities to those reported in the 2015 consolidated financial statements of Aegon.

18. Acquisitions / divestments

On January 18, 2016 Aegon Nederland N.V. signed an agreement to sell its commercial non-life insurance business, which includes the proxy and co-insurance run-off portfolios. The transaction is subject to approval by the Dutch Central Bank (De Nederlandsche Bank) and the Dutch Authority for Consumers and Markets (Autoriteit Consument & Markt). This sale is expected to be completed before July 1, 2016. This business continues to be part of Aegon’s reported numbers, until the transaction has been completed.

19. Events after the balance sheet date

On January 13, 2016, Aegon announced and started its EUR 400 million share buyback program to neutralize the dilutive effect of the cancellation of the preferred shares in 2013. The first tranche of EUR 200 million was completed on March 31, 2016 through the repurchase of 41.1 million shares. The second tranche of EUR 200 million was announced and started on April 1, 2016.

On April 11, 2016, Aegon announced the sale of two thirds of its UK annuity portfolio to Rothesay Life. Under the terms of the agreement, Aegon will reinsure GBP 6 billion of liabilities to Rothesay Life, followed by a Part VII transfer, which is subject to court approval. The reinsurance transaction is expected to result in an IFRS loss of approximately GBP 30 million (EUR 37 million) to be reported in the second quarter of 2016.

On May 3, 2016, Aegon announced it will buy BlackRock’s UK defined contribution (DC) platform and administration business. Through the agreement, Aegon will acquire approximately GBP 12 billion (EUR 15.2 billion) of assets and 350,000 customers from BlackRock, which serves institiutional and retail clients. The transaction is subject to closing conditions and a Part VII transfer of the underlying assets and liabilities to Aegon, which is subject to regulatory and court approval.

 

 

LOGO

   Unaudited


Table of Contents
 

 

  Condensed Consolidated Interim Financial Statements Q1 2016  

 

 

 

     33      

 

 

Disclaimers

Cautionary note regarding non-IFRS measures

This document includes the following non-IFRS financial measures: underlying earnings before tax, income tax and income before tax. These non-IFRS measures are calculated by consolidating on a proportionate basis Aegon’s joint ventures and associated companies. The reconciliation of these measures to the most comparable IFRS measure is provided in note 3 ‘Segment information’ of Aegon’s Condensed Consolidated Interim Financial Statements. Aegon believes that these non-IFRS measures, together with the IFRS information, provide meaningful information about the underlying operating results of Aegon’s business including insight into the financial measures that senior management uses in managing the business.

Forward-looking statements

The statements contained in this document that are not historical facts are forward-looking statements as defined in the US Private Securities Litigation Reform Act of 1995. The following are words that identify such forward-looking statements: aim, believe, estimate, target, intend, may, expect, anticipate, predict, project, counting on, plan, continue, want, forecast, goal, should, would, is confident, will, and similar expressions as they relate to Aegon. These statements are not guarantees of future performance and involve risks, uncertainties and assumptions that are difficult to predict. Aegon undertakes no obligation to publicly update or revise any forward-looking statements. Readers are cautioned not to place undue reliance on these forward-looking statements, which merely reflect company expectations at the time of writing. Actual results may differ materially from expectations conveyed in forward-looking statements due to changes caused by various risks and uncertainties. Such risks and uncertainties include but are not limited to the following:

 

t  

Changes in general economic conditions, particularly in the United States, the Netherlands and the United Kingdom;

t  

Changes in the performance of financial markets, including emerging markets, such as with regard to:

  The frequency and severity of defaults by issuers in Aegon’s fixed income investment portfolios;
  The effects of corporate bankruptcies and/or accounting restatements on the financial markets and the resulting decline in the value of equity and debt securities Aegon holds; and
  The effects of declining creditworthiness of certain private sector securities and the resulting decline in the value of sovereign exposure that Aegon holds;
t  

Changes in the performance of Aegon’s investment portfolio and decline in ratings of Aegon’s counterparties;

t  

Consequences of a potential (partial) break-up of the euro or the potential exit of the United Kingdom and/or Greece from the European Union;

t  

The frequency and severity of insured loss events;

t  

Changes affecting longevity, mortality, morbidity, persistence and other factors that may impact the profitability of Aegon’s insurance products;

t  

Reinsurers to whom Aegon has ceded significant underwriting risks may fail to meet their obligations;

t  

Changes affecting interest rate levels and continuing low or rapidly changing interest rate levels;

t  

Changes affecting currency exchange rates, in particular the EUR/USD and EUR/GBP exchange rates;

t  

Changes in the availability of, and costs associated with, liquidity sources such as bank and capital markets funding, as well as conditions in the credit markets in general such as changes in borrower and counterparty creditworthiness;

t  

Increasing levels of competition in the United States, the Netherlands, the United Kingdom and emerging markets;

t  

Changes in laws and regulations, particularly those affecting Aegon’s operations’ ability to hire and retain key personnel, the products Aegon sells, and the attractiveness of certain products to its consumers;

t  

Regulatory changes relating to the pensions, investment, and insurance industries in the jurisdictions in which Aegon operates;

t  

Standard setting initiatives of supranational standard setting bodies such as the Financial Stability Board and the International Association of Insurance Supervisors or changes to such standards that may have an impact on regional (such as EU), national or US federal or state level financial regulation or the application thereof to Aegon, including the designation of Aegon by the Financial Stability Board as a Global Systemically Important Insurer (G-SII).

t  

Changes in customer behavior and public opinion in general related to, among other things, the type of products also Aegon sells, including legal, regulatory or commercial necessity to meet changing customer expectations;

t  

Acts of God, acts of terrorism, acts of war and pandemics;

t  

Changes in the policies of central banks and/or governments;

t  

Lowering of one or more of Aegon’s debt ratings issued by recognized rating organizations and the adverse impact such action may have on Aegon’s ability to raise capital and on its liquidity and financial condition;

t  

Lowering of one or more of insurer financial strength ratings of Aegon’s insurance subsidiaries and the adverse impact such action may have on the premium writings, policy retention, profitability and liquidity of its insurance subsidiaries;

t  

The effect of the European Union’s Solvency II requirements and other regulations in other jurisdictions affecting the capital Aegon is required to maintain;

t  

Litigation or regulatory action that could require Aegon to pay significant damages or change the way Aegon does business;

t  

As Aegon’s operations support complex transactions and are highly dependent on the proper functioning of information technology, a computer system failure or security breach may disrupt Aegon’s business, damage its reputation and adversely affect its results of operations, financial condition and cash flows;

t  

Customer responsiveness to both new products and distribution channels;

t  

Competitive, legal, regulatory, or tax changes that affect profitability, the distribution cost of or demand for Aegon’s products;

t  

Changes in accounting regulations and policies or a change by Aegon in applying such regulations and policies, voluntarily or otherwise, which may affect Aegon’s reported results and shareholders’ equity;

t  

The impact of acquisitions and divestitures, restructurings, product withdrawals and other unusual items, including Aegon’s ability to integrate acquisitions and to obtain the anticipated results and synergies from acquisitions;

t  

Catastrophic events, either manmade or by nature, could result in material losses and significantly interrupt Aegon’s business; and

t  

Aegon’s failure to achieve anticipated levels of earnings or operational efficiencies as well as other cost saving and excess capital and leverage ratio management initiatives.

Further details of potential risks and uncertainties affecting Aegon are described in its filings with the Netherlands Authority for the Financial Markets and the US Securities and Exchange Commission, including the Annual Report. These forward-looking statements speak only as of the date of this document. Except as required by any applicable law or regulation, Aegon expressly disclaims any obligation or undertaking to release publicly any updates or revisions to any forward-looking statements contained herein to reflect any change in Aegon’s expectations with regard thereto or any change in events, conditions or circumstances on which any such statement is based.

 

 

Unaudited

   LOGO


Table of Contents
 

 

  Condensed Consolidated Interim Financial Statements Q1 2016  

 

 

 

             

 

 

Corporate and shareholder information

 

Headquarters      
Aegon N.V.      
P.O. Box 85      
2501 CB The Hague      
The Netherlands      
+ 31 (0) 70 344 32 10      
aegon.com   

 

Group Corporate Communications & Investor Relations

 

Media relations      
+ 31 (0) 70 344 89 56      
gcc@aegon.com      
Investor relations      
+ 31 (0) 70 344 83 05      
or 877 548 96 68 - toll free, USA only   
ir@aegon.com      

Publication dates quarterly results 2016 and 2017

August 11, 2016    Results second quarter 2016   
November 10, 2016    Results third quarter 2016   
February 17, 2017    Results fourth quarter 2016   

Aegon’s Q1 2016 press release and Financial Supplement are available on aegon.com.

About Aegon

Aegon’s roots go back more than 170 years – to the first half of the nineteenth century. Since then, Aegon has grown into an international company, with businesses in more than 20 countries in the Americas, Europe and Asia. Today, Aegon is one of the world’s leading financial services organizations, providing life insurance, pensions and asset management. Aegon’s purpose is to help people achieve a lifetime of financial security. More information: aegon.com.

 

 

Unaudited

   LOGO